Cited by 4,173RNA Interference and Gene DeliveryVirus-based gene therapy researchIntramuscular injections and effects

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Direct Gene Transfer into Mouse Muscle in Vivo

Wolff, Jon A., Malone, Robert W., Williams, Phillip, Chong, Wang, Acsadi, Gyula, Jani, Agnes, Felgner, Philip L.·1990·Science

DOI 10.1126/science.1690918

Open this paper in CoChat — free account

Abstract

RNA and DNA expression vectors containing genes for chloramphenicol acetyltransferase, luciferase, and β-galactosidase were separately injected into mouse skeletal muscle in vivo. Protein expression was readily detected in all cases, and no special delivery system was required for these effects. The extent of expression from both the RNA and DNA constructs was comparable to that obtained from fibroblasts transfected in vitro under optimal conditions. In situ cytochemical staining for β-galactosidase activity was localized to muscle cells following injection of the β-galactosidase DNA vector. After injection of the DNA luciferase expression vector, luciferase activity was present in the muscle for at least 2 months.

Integrity signals

Registry

Crossref · 10.1126/science.1690918

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,102
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954
Self-citation
Firefly Luciferase Gene: Structure and Expression in Mammalian Cells
de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., & Subramani, S. E. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.725 · Cited by 3,088
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs
Krieg, P. A., & Melton, D. A. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7057 · Cited by 1,533
The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.
Gorman, C. M., Merlino, G. T., Willingham, M. C., Pastan, I. H., & Howard, B. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.22.6777 · Cited by 1,257
Cationic liposome-mediated transfection
Felgner, P. L., & RINGOLD, G. M. (1989) · Nature · doi:10.1038/337387a0 · Cited by 989
Self-citation
Cationic liposome-mediated RNA transfection.
Malone, R. W., Felgner, P. L., & Verma, I. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6077 · Cited by 911
Self-citation
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer.
Price, J., Turner, D., & Cepko, C. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.156 · Cited by 870
Receptor-mediated gene delivery and expression in vivo.
Wu, G. Y., & Wu, C. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68081-0 · Cited by 636

Flagged first, then by citations

Show all 27 references

Research works printed but not linked: 3

FELGNER, P.L., FOCUS 11: 21 (1989).
FRANZINIARMSTRO.C, MYOLOGY: 125 (1986).
MALONE, R.W., FOCUS 11: 61 (1989).

Sorted by citations

Items 801–900 of 1,009

Maximizing the Translational Yield of mRNA Therapeutics by Minimizing 5′-UTRs
Trepotec, Z., Aneja, M. K., Geiger, J., Hasenpusch, G., Plank, C., & Rudolph, C. (2019) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0485 · Cited by 77
“E ven though the earliest reports of RNA transfection into cells date back to the early 1960s, and even though Wolf et al. 1 demonstrated the impressive potential of in-tramuscularly injected mRNA for expressing a reporter protein already in 1990, the ﬁeld of mRNA transcript therapy has progressed to clinical applicat…”
mRNA vaccines: the most recent clinical applications of synthetic mRNA
Kwon, S., Kwon, M., Im, S., Lee, K., & Lee, H. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01381-7 · Cited by 85
“In 1990, in vitro transcribed mRNA (IVT mRNA) was directly injected into a mouse skeleton muscle, and it expressed target proteins (Wolff et al. 1990).”
Background
Fabrication of sericin nanoparticles for controlled gene delivery
Das, S. K., Dey, T., & Kundu, S. C. (2013) · RSC Advances · doi:10.1039/c3ra44990d · Cited by 78
GENE THERAPY IN ORTHOPAEDIC SURGERY
Hannallah, D., Peterson, B., Lieberman, J. R., Fu, F. H., & Huard, J. (2002) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200206000-00023 · Cited by 78
Influenza vaccines: recent advances in production technologies
Bardiya, N., & Bae, J. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1874-1 · Cited by 78
Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA
Lundholm, P. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00404-6 · Cited by 78
Gene injection into canine myocardium as a useful model for studying gene expression in the heart of large mammals.
von Harsdorf, R., Schott, R. J., Shen, Y., Vatner, S. F., Mahdavi, V., & Nadal‐Ginard, B. (1993) · Circulation Research · doi:10.1161/01.res.72.3.688 · Cited by 78
Localization and Induced Expression of Fusion Genes in the Rat Lung
Hazinski, T. A., Ladd, P. A., & DeMatteo, C. A. (1991) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/4.3.206 · Cited by 78
Cancer therapy and vaccination
Aly, H. A. A. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.05.014 · Cited by 84
Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
Schmidt, C., & Schnierle, B. S. (2023) · Pathogens · doi:10.3390/pathogens12010138 · Cited by 78
“However, vaccines based on nucleic acids can circumvent this shortcoming, and RNA was first suggested as a vaccine candidate more than 30 years ago [1].”
Background
Water-Soluble and Nonionic Polyphosphoester: Synthesis, Degradation, Biocompatibility and Enhancement of Gene Expression in Mouse Muscle
Huang, S., Wang, J., Zhang, P., Mao, H., Zhuo, R., & Leong, K. W. (2004) · Biomacromolecules · doi:10.1021/bm034241l · Cited by 77
DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants
Pokorná, D., Rubio, I., & Müller, M. (2008) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-6-4 · Cited by 77
Muscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid
Li, S., MacLaughlin, F. C., Fewell, J. G., Gondo, M., Wang, J., Nicol, F., Dean, D. A., & Smith, L. C. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301419 · Cited by 77
Toward development of a non-viral gene therapeutic
Smith, J. G., Zhang, Y., & Niven, R. W. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00031-8 · Cited by 77
Cytotoxic T-Lymphocyte Responses Elicited to Wilms' Tumor Gene WT1 Product by DNA Vaccination
Tsuboi, A., Oka, Y., Ogawa, H., Elisseeva, O. A., Li, H., Kawasaki, K., Aozasa, K., Kishimoto, T., Udaka, K., & Sugiyama, H. (2000) · Journal of Clinical Immunology · doi:10.1023/a:1006637529995 · Cited by 77
Dexamethasone enhancement of gene expression after direct hepatic DNA injection.
Malone, R. W., Hickman, M. A., Lehmann‐Bruinsma, K., Sih, T. R., Walzem, R. L., Carlson, D. M., & Powell, J. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43966-x · Cited by 77
Self-citation
Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions
Tay, B. Q., Wright, Q., Ladwa, R., Perry, C., Leggatt, G., Simpson, F., Wells, J. W., Panizza, B. J., Frazer, I. H., & Cruz, J. L. G. (2021) · Vaccines · doi:10.3390/vaccines9050535 · Cited by 76
Viral and Synthetic RNA Vector Technologies and Applications
Schott, J. W., Morgan, M., Galla, M., & Schambach, A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.143 · Cited by 76
Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery
Żak, M. M., & Zangi, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101675 · Cited by 75
“missing hormone arginine vasopressin (AVP) [3,4] While early work on mRNA showed promising results, two fundamental barriers prevent mRNA therapeutics fro moving forward into clinical use.”
Influential
DNA vaccines, electroporation and their applications in cancer treatment
Lee, S.-H., Danishmalik, S. N., & Sin, J. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1035502 · Cited by 76
A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques
Schadeck, E. B., Sidhu, M. K., Egan, M. A., Chong, S.-Y., Piacente, P., Masood, A., Garcia-Hand, D., Cappello, S., Roopchand, V., Megati, S., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.10.035 · Cited by 76
Potency, Efficacy and Durability of DNA/DNA, DNA/Protein and Protein/Protein Based Vaccination Using gp63 Against Leishmania donovani in BALB/c Mice
Mazumder, S., Maji, M., Das, A., & Ali, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014644 · Cited by 76
Emerging strategies for cell and gene therapy of the muscular dystrophies
Muir, L. A., & Chamberlain, J. S. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001100 · Cited by 75
Dexamethasone-induced skeletal muscle atrophy was associated with upregulation of myostatin promoter activity
Qin, J., Du, R. H., Yang, Y.-Q., Zhang, H., Li, Q., Liu, L., Guan, H., Hou, J., & An, X.-R. (2012) · Research in Veterinary Science · doi:10.1016/j.rvsc.2012.07.018 · Cited by 78
Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity
van den Berg, J. H., Oosterhuis, K., Hennink, W. E., Storm, G., van der Aa, L. J., Engbersen, J. F. J., Haanen, J. B. A. G., Beijnen, J. H., Schumacher, T. N., & Nuijen, B. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.005 · Cited by 77
Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases
Barrett, P. N., Terpening, S. J., Snow, D. M., Cobb, R. R., & Kistner, O. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1357471 · Cited by 77
“site resulting in the expression of foreign proteins encoded by this nucleic acid [39].”
Background
Gene therapy in wound repair and regeneration
Yao, F., & Eriksson, E. (2000) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2000.00443.x · Cited by 75
The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine
Graham, R. A., Burchell, J., & Taylor‐Papadimitriou, J. (1996) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050254 · Cited by 76
Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response
Mittal, S. K., Aggarwal, N., Sailaja, G. S., van Olphen, A. L., HogenEsch, H., North, A., Hays, J. P., & Moffatt, S. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00170-5 · Cited by 77
Modulation of Antigen-Specific Humoral Responses in Rhesus Macaques by Using Cytokine cDNAs as DNA Vaccine Adjuvants
Kim, J. J., Yang, J.-S., VanCott, T. C., Lee, D. J., Manson, K. H., Wyand, M. S., Boyer, J., Ugen, K. E., & Weiner, D. B. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3427-3429.2000 · Cited by 76
Management of Peripheral Vascular Disease
Baumgärtner, I., Schainfeld, R. M., & Graziani, L. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104649 · Cited by 76
Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats
Maruyama, H., Ataka, K., Gejyo, F., Higuchi, N., Ito, Y., Hirahara, H., Imazeki, I., Hirata, M., Ichikawa, F., Neichi, T., et al. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301412 · Cited by 76
Protective immune responses elicited in mice by immunization with formulations of poly(lactide-co-glycolide) microparticles
McKeever, U., Barman, S. P., Hao, T., Chambers, P., Song, S., Lunsford, L. B., Hsu, Y., Roy, K., & Hedley, M. L. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00509-6 · Cited by 76
Cholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice
Hou, J., Liu, Y., Hsi, J. H., Wang, H., Tao, R., & Shao, Y. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28371 · Cited by 75
Unlocking the Therapeutic Applicability of LNP-mRNA: Chemistry, Formulation, and Clinical Strategies
Huang, X., Ma, Y., Ma, G., & Xia, Y. (2024) · Research · doi:10.34133/research.0370 · Cited by 76
“In the 1990s, the first published paper reported protein production after the injection of in vitro-transcribed (IVT) mRNA into mice [3], followed by various studies in the 1990s to 2000s [4].”
Background
Nucleic acid therapeutics: Past, present, and future
Naeem, S., Zhang, J., Zhang, Y., & Wang, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102440 · Cited by 81
Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccine to protect cats
Cupillard, L., Juillard, V., Latour, S., Colombet, G., Cachet, N., Richard, S., Blanchard, S., & Fischer, L. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.10.018 · Cited by 74
Production of anti-dengue NS1 monoclonal antibodies by DNA immunization
Puttikhunt, C., Kasinrerk, W., Srisa-ad, S., Duangchinda, T., Silakate, W., Moonsom, S., Sittisombut, N., & Malasit, P. (2003) · Journal of Virological Methods · doi:10.1016/s0166-0934(03)00045-4 · Cited by 75
Messenger RNA as a Source of Transposase for Sleeping Beauty Transposon–mediated Correction of Hereditary Tyrosinemia Type I
Wilber, A. C., Wangensteen, K. J., Chen, Y., Zhuo, L., Frandsen, J. L., Bell, J. B., Chen, Z. J., Ekker, S. C., McIvor, R. S., & Wang, X. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300160 · Cited by 75
Immunomodulation by Electrically Enhanced Delivery of Plasmid DNA Encoding IL-12 to Murine Skeletal Muscle
Lucas, M. L., & Heller, R. F. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0233 · Cited by 75
In Vivo Gene Transfer into Muscle via Electro-Sonoporation
Yamashita, Y., Shimada, M., Tachibana, K., Harimoto, N., Tsujita, E., Shirabe, K., Miyazaki, J., & Sugimachi, K. (2002) · Human Gene Therapy · doi:10.1089/10430340260395929 · Cited by 75
CD86 (B7-2) Can Function to Drive MHC-Restricted Antigen-Specific CTL Responses In Vivo
Agadjanyan, M. G., Kim, J. J., Trivedi, N. N., Wilson, D. M., Monzavi‐Karbassi, B., Morrison, L. D., Nottingham, L. K., Dentchev, T., Tsai, A., Dang, K., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3417 · Cited by 75
Gene transfer into somatic tissues by jet injection
Furth, P. A., Shamay, A., Wall, R. J., & Hennighausen, L. G. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90449-h · Cited by 75
mRNA therapeutics: New vaccination and beyond
Wei, H. Y., Zheng, L., & Wang, Z. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.02.022 · Cited by 77
“…a ﬁnal commercial product since the concept of mRNA-encoded drugs was conceived, which was marked by the discovery that in vitro synthesized mRNAs can serve as templates to drive protein expression when they were directly transfected into various eukaryotic cells [1] or injected in mice [2] .”
Background
Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene
Zhang, X., Divangahi, M., Ngai, P., Santosuosso, M., Millar, J., Zganiacz, A., Wang, J., Bramson, J. L., & Xing, Z. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.089 · Cited by 74
Electroporation-enhanced delivery of nucleic acid vaccines
Broderick, K. E., & Humeau, L. M. P. F. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.990890 · Cited by 74
Electroporation and ultrasound enhanced non-viral gene delivery in vitro and in vivo
Wells, D. J. (2009) · Cell Biology and Toxicology · doi:10.1007/s10565-009-9144-8 · Cited by 75
Plasmid DNA vaccination
Huygen, K. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.03.010 · Cited by 74
Intranasal administration of human immunodeficiency virus type‐1 (HIV‐1) DNA vaccine with interleukin‐2 expression plasmid enhances cell‐mediated immunity against HIV‐1
Xin, K., Hamajima, K., Sasaki, S., Honsho, A., TSUJI, T., Ishii, N., CAO, X., Lu, Y., FUKUSHIMA, J., Shapshak, P., et al. (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00533.x · Cited by 74
Synthesis of a novel series of cationic lipids that can act as efficient gene delivery vehicles through systematic heterocyclic substitution of cholesterol derivatives
Gao, H., & Hui, K. M. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301471 · Cited by 74
Human papilloma virus (HPV) and cervical cancer.
Furumoto, H., & Irahara, M. (2002) · PubMed · Cited by 73
Cap analogs with a hydrophobic photocleavable tag enable facile purification of fully capped mRNA with various cap structures
Inagaki, M., Abe, N., Li, Z., Nakashima, Y., Acharyya, S., Ogawa, K., Kawaguchi, D., Hiraoka, H., Banno, A., Meng, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38244-8 · Cited by 80
“DiPure (1) is an analog that links the Nb group via an acetal group at the 2’ position and has a free 3′ hydroxyl group since methylation of the 2′-hydroxyl has been reported to inhibit chain elongation fromm(7)G as well as that of the 3′-hydroxyl(39).”
BackgroundMethodInfluential
The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
Ye, Z., Harmon, J., Ni, W., Li, Y., Wich, D., & Xu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.2c12584 · Cited by 72
Skin targeted DNA vaccine delivery using electroporation in rabbits
Medi, B. M., & Singh, J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.035 · Cited by 73
Gene Transfer: How Can the Biological Barriers Be Overcome?
Escoffre, J., Teissié, J., & Rols, M. (2010) · Journal of Membrane Biology · doi:10.1007/s00232-010-9275-0 · Cited by 79
RNA interference for α-ENaC inhibits rat lung fluid absorption in vivo
Li, T., & Folkesson, H. G. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00205.2005 · Cited by 73
Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology
Walther, W., Stein, U., Fichtner, I., Malcherek, L., Lemm, M., & Schlag, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301350 · Cited by 73
Rational design of gene‐based vaccines
Barouch, D. H. (2005) · The Journal of Pathology · doi:10.1002/path.1874 · Cited by 73
Intravenous Delivery of Naked Plasmid DNA for in Vivo Cytokine Expression
Jiang, J., Yamato, E., & Miyazaki, J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6100 · Cited by 73
Plasmid DNA expression systems for the purpose of immunization
Davis, H. L. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80041-9 · Cited by 72
Complexes of non-cationic liposomes and histone H1 mediate efficient transfection of DNA without encapsulation
Hagstrom, J. E., Sebestyén, M. G., Budker, V. G., Ludtke, J. J., Fritz, J. D., & Wolff, J. A. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(96)00106-x · Cited by 73
Self-citation
Improved translation efficiency of therapeutic mRNA
Zarghampoor, F., Azarpira, N., Khatami, S. R., Behzad-Behbahani, A., & Foroughmand, A. M. (2019) · Gene · doi:10.1016/j.gene.2019.05.008 · Cited by 72
mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies
Chabanovska, O., Galow, A.-M., David, R., & Lemcke, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114002 · Cited by 81
“The very first use of mRNA to accomplish a protein production in vivo has been recorded nearly 30 years ago [21].”
Background
Plasmid DNA for Therapeutic Applications in Cancer
Martínez-Puente, D. H., Perez‐Trujillo, J. J., Zavala-Flores, L. M., García‐García, A., Villanueva-Olivo, A., Rodríguez‐Rocha, H., Valdés, J., Cárdenas, O. S., Montes‐de‐Oca‐Luna, R., & Loera‐Arias, M. D. J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091861 · Cited by 74
“reported the direct injection of naked DNA for the first time in 1990 [149].”
Background
Nanomaterials for mRNA ‐based therapeutics: Challenges and opportunities
Li, D., Liu, Q., Yang, M., Xu, H., Zhu, M., Zhang, Y., Xu, J., Tian, C., Yao, J., Wang, L., et al. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10492 · Cited by 74
“Since then, mRNA-based therapeutics have been exploited in a variety of application.(5) In 2002, the first clinical trial used ex vivo mRNA to transfect dendritic cells (DCs), aiming to stimulate cytotoxic T lymphocyte against cancer.”
Background
Recent Advances and Prospects in RNA Drug Development
Tani, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212284 · Cited by 78
Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond
Vallazza, B., Petri, S., Poleganov, M. A., Eberle, F., Kuhn, A. N., & Şahin, U. (2015) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1288 · Cited by 73
Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant Proteins
Otten, G. R., Schaefer, M. E., Doe, B., Liu, H., Srivastava, I. K., Megede, J. Z., Kazzaz, J., Lian, Y., Singh, M., Ugozzoli, M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8189-8200.2005 · Cited by 72
Optimization of an mRNA vaccine assisted with cyclodextrin-polyethyleneimine conjugates
Tan, L., Zheng, T., Li, M., Zhong, X., Tang, Y., Qin, M., & Sun, X. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00725-4 · Cited by 73
“Since the initial study in 1990 signified that the injection of exogenous mRNA can direct protein expression in vivo [1], mRNA has become the focus of molecular medicine research, especially in the field of vaccination.”
Background
Macrophage inflammatory protein-1α (MIP-1α) expression plasmid enhances DNA vaccine-induced immune response against HIV-1
Lu, Y., Xin, K.-Q., Hamajima, K., Tsuji, T., Aoki, I., YANG, J., Sasaki, S., FUKUSHIMA, J., Yoshimura, T., TODA, S., et al. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00793.x · Cited by 72
Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope
Richardson, J. P., Moraillon, A., Baud, S., Cuisinier, A., Sonigo, P., & Pancino, G. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9640-9649.1997 · Cited by 72
Nuclear import of polypeptides, polynucleotides and supramolecular complexes
Pouton, C. W. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00050-7 · Cited by 72
The Ubiquitin-Protein Ligase Nedd4 Targets Notch1 in Skeletal Muscle and Distinguishes the Subset of Atrophies Caused by Reduced Muscle Tension
Koncarevic, A., Jackman, R. W., & Kandarian, S. C. (2007) · The FASEB Journal · doi:10.1096/fj.06-6665com · Cited by 90
Development of dengue DNA vaccines
Danko, J., Beckett, C. G., & Porter, K. R. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.019 · Cited by 71
Recent advances in delivery of veterinary DNA vaccines against avian pathogens
Jazayeri, S. D., & Poh, C. L. (2019) · Veterinary Research · doi:10.1186/s13567-019-0698-z · Cited by 71
Mannose-Functionalized Biodegradable Nanoparticles Efficiently Deliver DNA Vaccine and Promote Anti-tumor Immunity
Sun, B., Zhao, X., Wu, Y., Cao, P., Movahedi, F., Liu, J., Wang, J., Xu, Z. P., & Gu, W. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c01401 · Cited by 72
Therapeutic Angiogenesis in the Management of Critical Limb Ischemia
Attanasio, S., & Snell, J. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e318199e9b7 · Cited by 71
FDA guidance on prophylactic DNA vaccines: Analysis and recommendations
Klinman, D. M., Klaschik, S., Tross, D., Shirota, H., & Steinhagen, F. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.025 · Cited by 71
Gene Transfer to Subdermal Tissues via a New Gene Gun Design
Dileo, J., Miller, T. E., Chesnoy, S., & Huang, L. (2003) · Human Gene Therapy · doi:10.1089/10430340360464732 · Cited by 71
Human Papillomavirus Type 16 E7 DNA Vaccine: Mutation in the Open Reading Frame of E7 Enhances Specific Cytotoxic T-Lymphocyte Induction and Antitumor Activity
Shi, W. K., Bu, P., Liu, J., Polack, A., Fisher, S. G., & Qiao, L. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7877-7881.1999 · Cited by 71
DNA vaccination against neu reduces breast cancer incidence and metastasis in mice
Lachman, L. B., Rao, X., Kremer, R. H., Özpolat, B., Kiriakova, G. M., & Price, J. E. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700300 · Cited by 71
Duchenne Muscular Dystrophy: Current Knowledge, Treatment, and Future Prospects
Biggar, W. D., Klamut, H. J., Demacio, P. C., Stevens, D. J., & Ray, P. N. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200208000-00012 · Cited by 71
Rearranged Ig Heavy Chain DNA Is Detectable in Cell-Free Blood Samples of Patients With B-Cell Neoplasia
Frickhofen, N., Müller, E., Sandherr, M., Binder, T. M., Bangerter, M., Wiest, C., Enz, M., & Heimpel, H. (1997) · Blood · doi:10.1182/blood.v90.12.4953 · Cited by 70
Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin.
Meng, X., Sawamura, D., Tamai, K., Hanada, K., Ishida, H., & Hashimoto, I. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1031 · Cited by 71
Intramuscular Injection of Expression Plasmid DNA Is an Effective Means of Long-Term Systemic Delivery of Interleukin-5
Tokui, M., Takei, I., Tashiro, F., Shimada, A., Kasuga, A., Ishii, M., Ishii, T., Takatsu, K., Saruta, T., & Miyazaki, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6485 · Cited by 71
Adaptation of fish to different environmental temperature by qualitative and quantitative changes in gene expression
Goldspink, G. (1995) · Journal of Thermal Biology · doi:10.1016/0306-4565(94)00045-k · Cited by 71
Vaccination with aShigellaDNA Vaccine Vector Induces Antigen-Specific CD8+T Cells and Antiviral Protective Immunity
Shata, M. T. M., & Hone, D. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.20.9665-9670.2001 · Cited by 71
Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes
Barron, L. G., Uyechi, L. S., & Szoka, F. C. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300929 · Cited by 71
Chapter 8 The Animal Models of Duchenne Muscular Dystrophy: Windows on the Pathophysiological Consequences of Dystrophin Deficiency
Hoffman, E. P., & Gorospe, J. R. M. (1991) · Current topics in membranes · doi:10.1016/s0070-2161(08)60785-6 · Cited by 73
Gene Transfer to the Thymus A Means of Abrogating the Immune Response to Recombinant Adenovirus
DeMatteo, R. P., Raper, S. E., Ahn, M., Fisher, K. J., Burke, C., Radu, A. P., Widera, G., Claytor, B. R., Barker, C. F., & Markmann, J. F. (1995) · Annals of Surgery · doi:10.1097/00000658-199509000-00002 · Cited by 71
Size and Charge Characterization of Lipid Nanoparticles for mRNA Vaccines
Malburet, C., Leclercq, L., Cotte, J., Thiebaud, J., Bazin, E., Garinot, M., & Cottet, H. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04778 · Cited by 75
Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development
Vallet, T., & Vignuzzi, M. (2025) · Viruses · doi:10.3390/v17040566 · Cited by 78
Vinyl Polymers as Non‐Viral Gene Delivery Carriers: Current Status and Prospects
Dubruel, P., & Schacht, E. H. (2006) · Macromolecular Bioscience · doi:10.1002/mabi.200600110 · Cited by 70
Gene electro‐transfer improves transduction by modifying the fate of intramuscular DNA
Cappelletti, M., Zampaglione, I., Rizzuto, G., Ciliberto, G., Monica, N. L., & Fattori, E. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.352 · Cited by 70
PML-RARA–targeted DNA vaccine induces protective immunity in a mouse model of leukemia
Padua, R. A., Larghero, J., Robin, M., Pogam, C. L., Schlageter, M., Muszlak, S., Frič, J., West, R., Rousselot, P. H., Phan, T. H., et al. (2003) · Nature Medicine · doi:10.1038/nm949 · Cited by 70
Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications
Muhammad, A., Champeimont, J., Mayr, U. B., Lubitz, W., & Kudela, P. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.149 · Cited by 70
Pulmonary DNA vaccination: Concepts, possibilities and perspectives
Bivas‐Benita, M., Ottenhoff, T. H. M., Junginger, H. E., & Borchard, G. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.028 · Cited by 71
The safety and longevity of DNA vaccines for fish
KANELLOS, Sylvester, S. R., AMBALI, Howard, & RUSSELL (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00688.x · Cited by 70
Muscle Delivery of Human Kallikrein Gene Reduces Blood Pressure in Hypertensive Rats
Xiong, W., Chao, J., & Chao, L. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.715 · Cited by 70
Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the
Drew, D. R., Lightowlers, M. W., & Strugnell, R. A. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00020-7 · Cited by 70

Authors: Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L.
Affiliations: University of Wisconsin–Madison (US)
Vical (United States) (US)
Departments of Pediatrics and Genetics, Waisman Center, University of Wisconsin, Madison, WI 53706.
ORCID: Malone, Robert W.
Felgner, Philip L.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1990-03-23
Volume: 247
Issue: 4949
Pages: 1465-1468
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.1690918
OpenAlex: W2014495927
Cited by: 4,173
References: 27
Citations by year: 2026: 96 · 2025: 151 · 2024: 186 · 2023: 201 · 2022: 188 · 2021: 187 · 2020: 81 · 2019: 74 · 2018: 62 · 2017: 66 · 2016: 56 · 2015: 77 · 2014: 68 · 2013: 93 · 2012: 90
FWCI: 26.43
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5k11hd000669-02)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 03352, HD00669-05, P30HD003352)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Health Sciences › Medicine › Emergency Medicine › Intramuscular injections and effects
Keywords: in vivo gene delivery, skeletal muscle, intramuscular injection, DNA vectors, chloramphenicol acetyltransferase, luciferase, beta-galactosidase, transgene expression, cytochemical staining, transfection
MeSH terms: Animals, Avian Sarcoma Viruses, Coleoptera, beta-Galactosidase, DNA, Escherichia coli, Genetic Vectors, Histocytochemistry, Luciferases, Muscles, RNA, Transfection, Chloramphenicol O-Acetyltransferase, Gene Expression, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Direct Gene Transfer into Mouse Muscle in Vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks